Boston Scientific Corporation Stock News

Les Funtleyder, portfolio manager for E Squared Capital Management, joins 'The Exchange' to discuss big cap pharma's Q1 performance, the dollar weakness contributing to biotech gains, and investment o

VREX vs. BSX: Which Stock Is the Better Value Option?

Investors are optimistic about Boston Scientific (BSX), led by impressive value-added acquisitions.

Boston Scientific stock (NYSE: BSX) has seen a fall of 3% in a month, compared with -5% returns for the broader S&P500 index.

Boston Scientific's (BSX) EMEA business grows above market, supported by the company's ongoing investments in emerging markets.

Boston Scientific came up short on margins in the fourth quarter, but reassuring guidance on revenue and improved margins in FY'23 seems to have smoothed that over. Boston Scientific has an above-aver

Boston Scientific's (BSX) organic revenues at each of its core business segments and geographies increase in the fourth quarter of 2022.

Boston Scientific Corporation (NYSE:BSX ) Q4 2022 Results Conference Call February 1, 2023 8:00 AM ET Company Participants Lauren Tengler - Vice President, Investor Relations Mike Mahoney - Chairman &

Thermo Fisher easily beat quarterly projections, while Boston Scientific was in line. TMO stock popped Wednesday while BSX stock also rose.

Boston Scientific (BSX) delivered earnings and revenue surprises of -4.26% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Boston Scientific Corp. stock BSX, +0.96% slid 5% in premarket trade Wednesday, after the medical device maker missed profit estimates for the fourth quarter. The company had net income of $126 millio

Investors are optimistic about Boston Scientific (BSX) on recent acquisitions and robust performance of the WATCHMAN device.

Boston Scientific (BSX) is expected to have registered strong growth in EMEA within structural heart, including TAVR, WATCHMAN, and other interventional cardiology therapies.

PETQ vs. BSX: Which Stock Is the Better Value Option?

MARLBOROUGH, Mass. , Jan. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 41st Annual J.P.